Assistive reproductive technology (ART) is an infertility treatment procedure. In this procedure, the sperm and eggs are taken out of the body and oocyte fertilization is done under laboratory environment. The fertilization process carried outside the body is known as In vitro fertilization (IVF). There are mainly two type of IVF procedures such IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without Intracytoplasmic Sperm Injection (ICSI).
Market Dynamics
Increase in infertility rates over the past years has supported growth of global assistive reproductive technologies market growth. For instance, according to the European society of Human Reproduction and Embryology (ESHRE) in 2018, more than 8 million babies, were born from IVF procedure. This rising number of IVF procedures is expected to boost the global assistive reproductive technology market growth.
Rising prevalence of infertility cases has led to an increase in demand for ART treatment techniques. Furthermore, higher rate of successful pregnancies and births resulting from ART cycles using fresh nondonor eggs or embryos is expected to facilitate the market growth. For instance, in 2016, as per IVF birth rate statistics, around 6.5 million babies were born using in-vitro fertilization (IVF). Moreover, according to the Centers for Disease Control and Prevention (CDC), around 1.6 percent of babies born in the United States each year are conceived through assisted reproductive technology (ART).
ART cycles, are carried out using various procedures such as fresh donor, frozen donor, fresh nondonor, frozen nondonor and embryo/egg banking. The choice of procedures also affects growth of the assistive reproductive technology market, depending upon the type of technology procedures are also chosen. In 2015, according to Centers for Disease Control and Prevention (CDC) 26% fresh nondonor and 42% frozen nondonor procedures were performed in the U.S. These factors are expected to propel the global assistive reproductive technology market growth.
Restraints of the Global Assistive Reproductive Technology Market
One of the major restraints of this market is the issue of legal parental rights, and few concern of people such as, whose names will be there on birth certificate and who will have parental responsibility. Such factors may refrain parents to make use of assistive reproductive technologies.
Key features of the study:
- This report provides in-depth analysis of the global assistive reproductive technology market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global assistive reproductive technology market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Cooper Surgical Inc., Hamilton Thorne, Inc., FUJIFILM Irvine Scientific, Inc., Merck KGaA, Nidacon International AB, Vitrolife AB, EMD Serono, Inc., INVO Bioscience, IVFtech ApS, Gonagen Medikal, Cook Medical Llc., and CellCura ASA
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global assistive reproductive technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the assistive reproductive technology market.
Detailed Segmentation
- Global Assistive Reproductive Technology Market, By Product Type:
- Global Assistive Reproductive Technology Market, By Technology:
- In-vitro fertilization (IVF)
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Others
- Global Assistive Reproductive Technology Market, By Procedure:
- Fresh Donor
- Frozen Donor
- Fresh Nondonor
- Frozen Nondonor
- Embryo/Egg Banking
- Others
- Global Assistive Reproductive Technology Market, By End User:
- Fertility Clinics
- IVF Center
- Hospital
- Global Assistive Reproductive Technology Market, By Region:
- North America
- By Product Type :
- By Technology:
- In-vitro fertilization (IVF)
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Others
- By Procedure :
- Fresh Donor
- Frozen Donor
- Fresh Nondonor
- Frozen Nondonor
- Embryo/Egg Banking
- Others
- By End User:
- Fertility Clinics
- IVF Center
- Hospital
- By Country:
- Europe
- By Product Type :
- By Technology:
- In-vitro fertilization (IVF)
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Others
- By Procedure :
- Fresh Donor
- Frozen Donor
- Fresh Nondonor
- Frozen Nondonor
- Embryo/Egg Banking
- Others
- By End User:
- Fertility Clinics
- IVF Center
- Hospital
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type :
- By Technology:
- In-vitro fertilization (IVF)
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Others
- By Procedure :
- Fresh Donor
- Frozen Donor
- Fresh Nondonor
- Frozen Nondonor
- Embryo/Egg Banking
- Others
- By End User:
- Fertility Clinics
- IVF Center
- Hospital
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Product Type :
- By Technology:
- In-vitro fertilization (IVF)
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Others
- By Procedure :
- Fresh Donor
- Frozen Donor
- Fresh Nondonor
- Frozen Nondonor
- Embryo/Egg Banking
- Others
- By End User:
- Fertility Clinics
- IVF Center
- Hospital
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- By Product Type :
- By Technology:
- In-vitro fertilization (IVF)
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Others
- By Procedure :
- Fresh Donor
- Frozen Donor
- Fresh Nondonor
- Frozen Nondonor
- Embryo/Egg Banking
- Others
- By End User:
- Fertility Clinics
- IVF Center
- Hospital
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type :
- By Technology:
- In-vitro fertilization (IVF)
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Others
- By Procedure :
- Fresh Donor
- Frozen Donor
- Fresh Nondonor
- Frozen Nondonor
- Embryo/Egg Banking
- Others
- By End User:
- Fertility Clinics
- IVF Center
- Hospital
- By Country/Region:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Cooper Surgical Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Hamilton Thorne, Inc.
- FUJIFILM Irvine Scientific, Inc.
- Nidacon International AB
- Vitrolife AB
- EMD Serono, Inc.
- INVO Bioscience
- IVFtech ApS
- Gonagen Medikal
- Cook Medical LLC
- CellCura ASA
- Merck KGaA
“*” marked represents similar segmentation in other categories in the respective section.
